Involvement of annexin-I in glucose-induced insulin secretion in rat pancreatic islets. 1995

M Ohnishi, and M Tokuda, and T Masaki, and T Fujimura, and Y Tai, and T Itano, and H Matsui, and T Ishida, and R Konishi, and J Takahara
Department of Internal Medicine, Kagawa Medical School, Japan.

Annexin-I was demonstrated to specifically present in islets and not in exocrine tissues of the rat pancreas and to have a diffuse and homogeneous distribution in all islet cells in our previous study. In the present report, to clarify the functions of annexin-I in rat pancreatic islets, especially in beta-cells, we investigated the role of annexin-I in insulin secretion. Immunoelectron microscopic analysis of pancreatic beta-cells demonstrated that immunogold particles reactive to annexin-I were almost exclusively observed on most of the insulin-containing granules (approximately 90%) and less frequently located in cytosol and other organelles, such as the endoplasmic reticulum and mitochondria. The number of annexin-I gold particles located on insulin granules after oral glucose administration was significantly increased compared with that observed in fasted rats. Moreover, when the isolated islets were stimulated by a high concentration of glucose (20 mM), the phosphorylation of annexin-I was markedly enhanced, and it was synchronized to insulin secretion. This phosphorylation mainly occurred on serine residues. H-7 (100 microM), a potent inhibitor of protein kinase-C, inhibited the phosphorylation to about 90%. These findings suggest that annexin-I might be involved in the regulatory mechanism of glucose-induced insulin secretion in rat pancreatic islets via phosphorylation-dephosphorylation processes.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015388 Organelles Specific particles of membrane-bound organized living substances present in eukaryotic cells, such as the MITOCHONDRIA; the GOLGI APPARATUS; ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES. Organelle

Related Publications

M Ohnishi, and M Tokuda, and T Masaki, and T Fujimura, and Y Tai, and T Itano, and H Matsui, and T Ishida, and R Konishi, and J Takahara
January 2007, Cell biochemistry and function,
M Ohnishi, and M Tokuda, and T Masaki, and T Fujimura, and Y Tai, and T Itano, and H Matsui, and T Ishida, and R Konishi, and J Takahara
December 2002, FEBS letters,
M Ohnishi, and M Tokuda, and T Masaki, and T Fujimura, and Y Tai, and T Itano, and H Matsui, and T Ishida, and R Konishi, and J Takahara
November 2002, FEBS letters,
M Ohnishi, and M Tokuda, and T Masaki, and T Fujimura, and Y Tai, and T Itano, and H Matsui, and T Ishida, and R Konishi, and J Takahara
January 2014, Biochemical and biophysical research communications,
M Ohnishi, and M Tokuda, and T Masaki, and T Fujimura, and Y Tai, and T Itano, and H Matsui, and T Ishida, and R Konishi, and J Takahara
January 1983, Experimental and clinical endocrinology,
M Ohnishi, and M Tokuda, and T Masaki, and T Fujimura, and Y Tai, and T Itano, and H Matsui, and T Ishida, and R Konishi, and J Takahara
October 1996, The American journal of physiology,
M Ohnishi, and M Tokuda, and T Masaki, and T Fujimura, and Y Tai, and T Itano, and H Matsui, and T Ishida, and R Konishi, and J Takahara
February 2000, Journal of biochemistry,
M Ohnishi, and M Tokuda, and T Masaki, and T Fujimura, and Y Tai, and T Itano, and H Matsui, and T Ishida, and R Konishi, and J Takahara
April 2005, Toxicology letters,
M Ohnishi, and M Tokuda, and T Masaki, and T Fujimura, and Y Tai, and T Itano, and H Matsui, and T Ishida, and R Konishi, and J Takahara
November 1987, The Journal of endocrinology,
M Ohnishi, and M Tokuda, and T Masaki, and T Fujimura, and Y Tai, and T Itano, and H Matsui, and T Ishida, and R Konishi, and J Takahara
July 1998, Diabetes,
Copied contents to your clipboard!